Literature DB >> 21903191

Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.

Samantha J Benton1, Yuxiang Hu, Fang Xie, Kenneth Kupfer, Seok-Won Lee, Laura A Magee, Peter von Dadelszen.   

Abstract

OBJECTIVE: Placental growth factor and soluble Fms-like tyrosine kinase-1 may be potential diagnostic markers of preeclampsia. We compared performances of 2 immunoassays, the Triage placental growth factor assay and the Elecsys soluble Fms-like tyrosine kinase-1/placental growth factor ratio in diagnosing preeclampsia. STUDY
DESIGN: A single site, case-control study of 44 patients with preeclampsia and 84 matched normal pregnant controls. Samples were collected at the time of diagnosis. Assays were performed according to product inserts.
RESULTS: Both assays had optimal performance in diagnosing early-onset preeclampsia with area under the receiver operating characteristic curves of 0.99 (Triage: 100% sensitivity, 96% specificity; Elecsys: 64% sensitivity, 100% specificity for early-onset preeclampsia). Reassignment of the Elecsys cutoff for a positive test based on receiver operating characteristic curves increased sensitivity to 92%.
CONCLUSION: Using product insert cutoffs, Triage appears to have greater sensitivity at only a small reduction in specificity compared with Elecsys in the diagnosis of early-onset preeclampsia. A different cutoff may improve Elecsys sensitivity.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903191     DOI: 10.1016/j.ajog.2011.06.058

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

2.  Increased circulating levels of Epidermal Growth Factor-like Domain 7 in pregnant women affected by preeclampsia.

Authors:  Micol Massimiani; Lauretta A Lacko; Clare S Burke Swanson; Silvia Salvi; Lissenya B Argueta; Sascia Moresi; Sergio Ferrazzani; Shari E Gelber; Rebecca N Baergen; Nicola Toschi; Luisa Campagnolo; Heidi Stuhlmann
Journal:  Transl Res       Date:  2018-12-25       Impact factor: 7.012

Review 3.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

4.  Pre-eclampsia: proteinuria in pre-eclampsia-does it matter any more?

Authors:  Mark A Brown
Journal:  Nat Rev Nephrol       Date:  2012-08-21       Impact factor: 28.314

5.  Characterization of antibody specificities associated with preeclampsia.

Authors:  Serra E Elliott; Nicholas F Parchim; Chen Liu; Yang Xia; Rodney E Kellems; Alex R Soffici; Patrick S Daugherty
Journal:  Hypertension       Date:  2014-01-20       Impact factor: 10.190

6.  Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.

Authors:  H Lehnen; N Mosblech; T Reineke; A Puchooa; I Menke-Möllers; U Zechner; U Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

7.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

8.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

9.  A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients.

Authors:  Pooja Mathur; Poonam Mathur; Laxmi Maru; Anupama Dave
Journal:  J Obstet Gynaecol India       Date:  2015-11-19

10.  Photoplethysmography and Heart Rate Variability for the Diagnosis of Preeclampsia.

Authors:  Tammy Y Euliano; Kostas Michalopoulos; Savyasachi Singh; Anthony R Gregg; Mariem Del Rio; Terrie Vasilopoulos; Amber M Johnson; Allison Onkala; Shalom Darmanjian; Neil R Euliano; Monique Ho
Journal:  Anesth Analg       Date:  2018-03       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.